SHADAN MARTHA — SEC insider filings
SEC reporting owner CIK 1871700. 35 insider filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2021-07-14 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 1,466 shares, $151,547 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 97.
- Largest priced transaction: sale of 1,070 shares @ $103.37 ($110,610) in LEMAITRE VASCULAR INC, filed 2024-11-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | Director | 28 | — | 2 legs · 1,466 sh · $151,547 | 88 |
| CVRx, Inc. (CVRX) | Director | 7 | — | — | 9 |
Insider filings — SHADAN MARTHA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.54 (derivative) @ $0 · Grant/award (A): 0.65 (derivative) @ $0 · Grant/award (A): 0.89 (derivative) @ $0 · Grant/award (A): 1.00 (derivative) @ $0 · Grant/award (A): 1.66 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.47 (derivative) @ $0 · Grant/award (A): 0.56 (derivative) @ $0 · Grant/award (A): 0.76 (derivative) @ $0 · Grant/award (A): 0.86 (derivative) @ $0 · Grant/award (A): 1.43 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.39 (derivative) @ $0 · Grant/award (A): 0.47 (derivative) @ $0 · Grant/award (A): 0.64 (derivative) @ $0 · Grant/award (A): 0.73 (derivative) @ $0 · Grant/award (A): 1.21 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 476 @ $0 · Option exercise (M): 1 @ $0 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 5 @ $0 · Option exercise (M): 5 @ $0 · Option exercise (M): 5 (derivative) @ $0 · Option exercise (M): 5 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 533 @ $0 · Grant/award (A): 3,431 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 2 @ $0 · Option exercise (M): 3 @ $0 · Option exercise (M): 2 (derivative) @ $0 · Option exercise (M): 3 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 1 @ $0 · Grant/award (A): 0.47 (derivative) @ $0 · Grant/award (A): 0.47 (derivative) @ $0 · Grant/award (A): 0.81 (derivative) @ $0 · Grant/award (A): 0.97 (derivative) @ $0 · Grant/award (A): 0.99 (derivative) @ $0 · +1 more | EDGAR |
| 2025-09-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.42 (derivative) @ $0 · Grant/award (A): 0.42 (derivative) @ $0 · Grant/award (A): 0.71 (derivative) @ $0 · Grant/award (A): 0.85 (derivative) @ $0 · Grant/award (A): 0.87 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.50 (derivative) @ $0 · Grant/award (A): 0.50 (derivative) @ $0 · Grant/award (A): 0.85 (derivative) @ $0 · Grant/award (A): 1.02 (derivative) @ $0 · Grant/award (A): 1.04 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.48 (derivative) @ $0 · Grant/award (A): 0.48 (derivative) @ $0 · Grant/award (A): 0.82 (derivative) @ $0 · Grant/award (A): 0.98 (derivative) @ $0 · Grant/award (A): 1.00 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 204 @ $0 · Option exercise (M): 1 @ $0 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 3 @ $0 · Option exercise (M): 3 @ $0 · Option exercise (M): 3 (derivative) @ $0 · Option exercise (M): 3 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 1 @ $0 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 420 @ $0 · Grant/award (A): 2,594 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.63 (derivative) @ $0 · Grant/award (A): 0.63 (derivative) @ $0 · Grant/award (A): 0.80 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 1,070 @ $47.19 · Sale (S): 1,070 @ $103.37 · Sale (S): 396 @ $103.38 · Option exercise (M): 1,070 (derivative) @ $47.19 | EDGAR |
| 2024-09-03 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.73 (derivative) @ $0 · Grant/award (A): 0.73 (derivative) @ $0 · Grant/award (A): 0.93 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4/A | CVRx, Inc. (CVRX) | Grant/award (A): 27,250 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 20,961 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.81 (derivative) @ $0 · Grant/award (A): 0.81 (derivative) @ $0 · Grant/award (A): 1.04 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.96 (derivative) @ $0 · Grant/award (A): 0.96 (derivative) @ $0 · Grant/award (A): 1.23 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 593 @ $0 · Option exercise (M): 1 @ $0 · Option exercise (M): 1.99 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 1 @ $0 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2023-12-12 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 512 @ $0 · Grant/award (A): 2,772 (derivative) @ $0 | EDGAR |
| 2023-12-04 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1.59 (derivative) @ $0 | EDGAR |
| 2023-09-05 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1.44 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 12,012 (derivative) @ $0 | EDGAR |
| 2023-06-05 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1.30 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1.66 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 593 @ $0 · Grant/award (A): 3,209 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 26,985 (derivative) @ $0 | EDGAR |
| 2021-07-14 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 9,988 (derivative) @ $0 · Grant/award (A): 24,885 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-07-14 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871700 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs